GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Dipna Pharmachem Ltd (BOM:543594) » Definitions » DeferredTaxAndRevenue

Dipna Pharmachem (BOM:543594) DeferredTaxAndRevenue : ₹0 Mil (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Dipna Pharmachem DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Dipna Pharmachem's current deferred tax and revenue for the quarter that ended in Sep. 2024 was ₹0 Mil.

Dipna Pharmachem DeferredTaxAndRevenue Historical Data

The historical data trend for Dipna Pharmachem's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dipna Pharmachem DeferredTaxAndRevenue Chart

Dipna Pharmachem Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
DeferredTaxAndRevenue
- - - - -

Dipna Pharmachem Semi-Annual Data
Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only - - - - -

Dipna Pharmachem DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of Dipna Pharmachem's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Dipna Pharmachem Business Description

Traded in Other Exchanges
N/A
Address
A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, GJ, IND, 380055
Dipna Pharmachem Ltd is engaged in the trading and distribution of a wide range of pharmaceutical raw materials which is also known as APIs (Active Pharmaceutical Ingredients), Excipient and chemical formulation products. The company's product portfolio comprises of Hydrocortisone Acetate, Aceclofenac, Asprin, Levofloxacin, and others.

Dipna Pharmachem Headlines

No Headlines